213 related articles for article (PubMed ID: 34323038)
1. [Constructing Brain Aβ-Targeting Nanoparticles Loaded with EGCG for Treating Alzheimer's Disease in Mice].
Yang P; Guo Q; Xu ST; Sheng DY; Zhang QZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):605-611. PubMed ID: 34323038
[TBL] [Abstract][Full Text] [Related]
2. Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice.
Lee JW; Lee YK; Ban JO; Ha TY; Yun YP; Han SB; Oh KW; Hong JT
J Nutr; 2009 Oct; 139(10):1987-93. PubMed ID: 19656855
[TBL] [Abstract][Full Text] [Related]
3. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
Cano A; Ettcheto M; Chang JH; Barroso E; Espina M; Kühne BA; Barenys M; Auladell C; Folch J; Souto EB; Camins A; Turowski P; García ML
J Control Release; 2019 May; 301():62-75. PubMed ID: 30876953
[TBL] [Abstract][Full Text] [Related]
4. [Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs].
He M; Liu MY; Wang S; Tang QS; Yao WF; Zhao HS; Wei MJ
Zhong Yao Cai; 2012 Oct; 35(10):1641-4. PubMed ID: 23627134
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-Gallate Provides Protection Against Alzheimer's Disease-Induced Learning and Memory Impairments in Rats.
Nan S; Wang P; Zhang Y; Fan J
Drug Des Devel Ther; 2021; 15():2013-2024. PubMed ID: 34012254
[TBL] [Abstract][Full Text] [Related]
7. Brain-targeted co-delivery of β-amyloid converting enzyme 1 shRNA and epigallocatechin-3-gallate by multifunctional nanocarriers for Alzheimer's disease treatment.
Lv L; Yang F; Li H; Yuan J
IUBMB Life; 2020 Aug; 72(8):1819-1829. PubMed ID: 32668504
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus.
Jia N; Han K; Kong JJ; Zhang XM; Sha S; Ren GR; Cao YP
Mol Cell Biochem; 2013 Aug; 380(1-2):211-8. PubMed ID: 23660953
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties.
Lee YJ; Choi DY; Yun YP; Han SB; Oh KW; Hong JT
J Nutr Biochem; 2013 Jan; 24(1):298-310. PubMed ID: 22959056
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model.
Walker JM; Klakotskaia D; Ajit D; Weisman GA; Wood WG; Sun GY; Serfozo P; Simonyi A; Schachtman TR
J Alzheimers Dis; 2015; 44(2):561-72. PubMed ID: 25318545
[TBL] [Abstract][Full Text] [Related]
11. Curcumin alleviates Alzheimer's disease by inhibiting inflammatory response, oxidative stress and activating the AMPK pathway.
Shao S; Ye X; Su W; Wang Y
J Chem Neuroanat; 2023 Dec; 134():102363. PubMed ID: 37989445
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate-derived carbonized polymer dots: A multifunctional scavenger targeting Alzheimer's β-amyloid plaques.
Lin X; Liu W; Dong X; Sun Y
Acta Biomater; 2023 Feb; 157():524-537. PubMed ID: 36503076
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis.
Rasoolijazi H; Joghataie MT; Roghani M; Nobakht M
Iran Biomed J; 2007 Oct; 11(4):237-43. PubMed ID: 18392085
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin gallate attenuates amyloid β-induced inflammation and neurotoxicity in EOC 13.31 microglia.
Cheng-Chung Wei J; Huang HC; Chen WJ; Huang CN; Peng CH; Lin CL
Eur J Pharmacol; 2016 Jan; 770():16-24. PubMed ID: 26643169
[TBL] [Abstract][Full Text] [Related]
15. Increased BBB permeability contributes to EGCG-caused cognitive function improvement in natural aging rats: pharmacokinetic and distribution analyses.
Wei BB; Liu MY; Zhong X; Yao WF; Wei MJ
Acta Pharmacol Sin; 2019 Nov; 40(11):1490-1500. PubMed ID: 31092885
[TBL] [Abstract][Full Text] [Related]
16. [Effect of aqueous extract of Corni Fructus on Aβ_(25-35)-induced brain injury and neuroinflammation in mice with Alzheimer's disease].
Hao FX; Zeng MN; Cao B; Liang XW; Jiao XM; Feng WS; Zheng XK
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):4015-4026. PubMed ID: 37802769
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of Alpinae Oxyphyllae Fructus extracts on lipopolysaccharide-induced animal model of Alzheimer's disease.
Wang Y; Wang M; Fan K; Li T; Yan T; Wu B; Bi K; Jia Y
J Ethnopharmacol; 2018 May; 217():98-106. PubMed ID: 29447949
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer's disease in a rat/mouse model: a systematic review.
Khalifa MKA; Abdel-Sattar SA; Amin OM; Kohaf NA; Zaky HS; Abd El-Fattah MA; Mohammed KHA; Badawi NM; Mansoor I; Eassa HA
Daru; 2024 Jun; 32(1):319-337. PubMed ID: 38079104
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-gallate Alleviates Cognitive Deficits in APP/PS1 Mice.
Bao J; Liu W; Zhou HY; Gui YR; Yang YH; Wu MJ; Xiao YF; Shang JT; Long GF; Shu XJ
Curr Med Sci; 2020 Feb; 40(1):18-27. PubMed ID: 32166661
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice.
Ettcheto M; Cano A; Manzine PR; Busquets O; Verdaguer E; Castro-Torres RD; García ML; Beas-Zarate C; Olloquequi J; Auladell C; Folch J; Camins A
Mol Neurobiol; 2020 Apr; 57(4):1814-1827. PubMed ID: 31838720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
